Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Accumulated Expenses (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Accumulated Expenses for 10 consecutive years, with $456066.0 as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Expenses fell 83.67% to $456066.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $456066.0, a 83.67% decrease, with the full-year FY2024 number at $3.9 million, up 129.29% from a year prior.
  • Accumulated Expenses was $456066.0 for Q3 2025 at KORU Medical Systems, down from $3.6 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $4.0 million in Q1 2025 to a low of $444251.0 in Q2 2024.
  • A 5-year average of $2.0 million and a median of $1.8 million in 2021 define the central range for Accumulated Expenses.
  • Biggest YoY gain for Accumulated Expenses was 718.35% in 2025; the steepest drop was 83.67% in 2025.
  • KORU Medical Systems' Accumulated Expenses stood at $2.7 million in 2021, then crashed by 79.98% to $542399.0 in 2022, then skyrocketed by 215.53% to $1.7 million in 2023, then soared by 129.29% to $3.9 million in 2024, then crashed by 88.38% to $456066.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Accumulated Expenses are $456066.0 (Q3 2025), $3.6 million (Q2 2025), and $4.0 million (Q1 2025).